Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-13,979
Closed -$2.66M – 8981
2015
Q2
$2.66M Buy
13,979
+8,609
+160% +$1.42M ﹤0.01% 2699
2015
Q1
$885K Sell
5,370
-18,832
-78% -$2.38M ﹤0.01% 3680
2014
Q4
$2.96M Buy
24,202
+24,096
+22,732% +$2.44M ﹤0.01% 2537
2014
Q3
$7K Buy
106
+60
+130% +$2.87K ﹤0.01% 9234
2014
Q2
$2K Buy
+46
New +$1.59K ﹤0.01% 10147
2014
Q1
– Sell
-254
Closed -$7K – 11256
2013
Q4
$7K Sell
254
-2,355
-90% -$63.1K ﹤0.01% 9385
2013
Q3
$68K Buy
+2,609
New +$50.2K ﹤0.01% 6466

UBS Group's RCPT Position: Q3 2015 in Review

UBS Group sold out of Receptos (RCPT) in Q3 2015, closing a stake of 13,979 shares — an estimated $2.66M sold.

UBS Group first reported a position in RCPT in Q3 2013 and held it in 7 quarters. The position peaked at $2.96M in Q4 2014. 0 funds tracked by Wall St. Rank hold RCPT as of Q3 2015.

  • UBS Group reported no remaining Receptos position as of Q3 2015 after selling out during the quarter.
  • UBS Group sold 13,979 Receptos shares in Q3 2015, an estimated $2.66M.
  • UBS Group first reported a position in Receptos in Q3 2013 and held it in 7 quarters.
  • UBS Group's Receptos position peaked at $2.96M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Receptos as of Q3 2015.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.